Real-World Biomarker Testing and Treatment Patterns for Locally Advanced and Metastatic Non-Small Cell Lung Cancer in Canada

被引：0
|
作者：
Laforty, C. [1 ]
Tong, M. [1 ]
Sharma, A. [2 ]
Kim, Y. [3 ]
Devost, N. [3 ]
Qadeer, R. [3 ]
Navani, V. [4 ]
机构：
[1] IQVIA, Toronto, ON, Canada
[2] IQVIA, Ottawa, ON, Canada
[3] AstraZeneca Canada, Mississauga, ON, Canada
[4] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Locally Advanced and Metastatic NSCLC; Biomarker; Treatment Patterns;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.12G.02
引用
收藏
页码：S656 / S657
页数：2
相关论文
共 50 条
  • [31] Real-world treatment patterns, clinical practice and outcomes for locally advanced, non resectable, non-small cell lung cancer from the French ESME Lung database
    Girard, N.
    Perol, M.
    Simon, G.
    Valette, C. Audigier
    Gervais, R.
    Debieuvre, D.
    Schott, R.
    Quantin, X.
    Coudert, B.
    Lena, H.
    Carton, M.
    Robain, M.
    Filleron, T.
    Chouaid, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [32] The Real-World Efficacy and Safety of Anlotinib Treatment for Advanced Non-Small Cell Lung Cancer
    Wang, F.
    Jin, F.
    Wang, S.
    Zhu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S673 - S673
  • [33] REAL-WORLD PATIENT CHARACTERISTICS, TREATMENT PATTERNS, AND SURVIVAL AMONG LOCALLY-ADVANCED/METASTATIC ALK plus NON-SMALL CELL LUNG CANCER PATIENTS IN LATIN AMERICA
    Arrieta, O.
    Mascheroni, M. B.
    Recondo, G.
    Kaen, D.
    Zhang, J.
    Patel, D.
    Swallow, E.
    Balu, S.
    Camacho, O. C.
    Ratto, B.
    Kageleiry, A.
    Stein, K.
    Degun, R.
    Martin, C.
    VALUE IN HEALTH, 2015, 18 (07) : A817 - A817
  • [34] Real-World PD-L1 Testing Patterns for Patients with Advanced Non-Small Cell Lung Cancer in Greece
    Kokkotou, E.
    Charpidou, A.
    Papaspiliou, A.
    Stournara, L.
    Grammatikou, V.
    Ejzykowicz, F.
    Syrigos, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S660 - S660
  • [35] Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
    Greenhalgh, J.
    McLeod, C.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    Dundar, Y.
    Oyee, J.
    Dickson, R.
    Davis, H.
    Green, J.
    McKenna, E.
    Pearson, M.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 33 - 39
  • [36] Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancer
    Leow, CH
    Liam, CK
    RESPIROLOGY, 2005, 10 (05) : 629 - 635
  • [37] Real-world treatment patterns and clinical outcomes in early stage non-small cell lung cancer (eNSCLC) in Canada.
    O'Sullivan, Dylan E.
    Boyne, Devon J.
    Ford-Sahibzada, Chelsea
    Inskip, Jessica A.
    Smith, Christopher J.
    Sripada, Kaushik
    Brenner, Darren R.
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals
    van de Ven, Michiel
    Koffijberg, Hendrik
    Retel, Valesca
    Monkhorst, Kim
    Smit, Egbert
    van Harten, Wim
    IJzerman, Maarten
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2021, 23 (04): : 484 - 494
  • [39] CrizotinibIn Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Monique P. Curran
    Drugs, 2012, 72 (1) : 99 - 107
  • [40] Overall survival and treatment patterns among real-world patients with metastatic non-small cell lung cancer not previously treated with systemic therapy for advanced cancer
    Simeone, Jason C.
    Nordstrom, Beth
    Patel, Ketan
    Klein, Alyssa B.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345